Neuronal GSK3β Protects Against Amyloid Pathology by Regulating APP Degradation

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Examination of Akt and <scp>GSK3β</scp> in <scp>BDNF</scp>‐mediated reductions in <scp>BACE1</scp> activity in neuronal cells2024 · 11 citations
2. 2The dual role of glycogen synthase kinase-3 beta (GSK3β) in neurodegenerative pathologies: interplay between autophagy and disease progression2025
3. 3Role of GSK-3 Inhibition in Alzheimer’s Disease Therapy2025 · 2 citations
4. 4Targeting GSK3β with a Synthetic Small Molecule Rescues Neurotoxicity in a Cellular Model of Alzheimer’s Disease2026
5. 5Regional differences in dendritic spine morphology and innervation of the trisynaptic circuit of a mouse model of GSK-3β overexpression2026